Literature DB >> 30058712

Clostridium butyricum promotes intestinal motility by regulation of TLR2 in interstitial cells of Cajal.

S-J Sui1, Z-B Tian, Q-C Wang, R Chen, J Nie, J-S Li, L-Z Wei.   

Abstract

OBJECTIVE: Clostridium butyricum (C. butyricum) as a probiotic has been reported to have an important role in the pathogenesis of gastrointestinal diseases. However, the effects of C. butyricum on regulation of intestinal motility of ulcerative colitis (UC) remain unclear. Our study aimed to explore the cross-regulation effect of C. butyricum and toll-like receptor 2 (TLR-2) on UC.
MATERIALS AND METHODS: Interstitial cells of Cajal (ICCs) were treated by C. butyricum for 2 h, the mRNA and protein levels of TLR-2, IL-6, and IL-8 were detected by RT-qPCR and Western blot. Then, TLR2-specific small interfering RNA (si-TLR2) was transfected into ICCs, and the relative expressions of IL-6 and IL-8, SCF, cell viability, ghrelin, SP, and ET were measured by RT-qPCR, Western blot, CCK-8, and ELISA. Besides, the signal pathways of NF-κB and JNK were determined by Western blot.
RESULTS: C. butyricum significantly increased TLR2, IL-6, and IL-8 expressions in ICCs. However, TLR2 silence alleviated C. butyricum-induced IL-6 and IL-8 expressions. Moreover, TLR2 silence significantly inhibited C. butyricum-induced cell viability in ICCs. Additionally, C. butyricum significantly increased SCF expression and promoted the secretion of ghrelin and SP. However, a significant reduction in the levels of SCF, ghrelin, and SP was evident in the silence of TLR2 expression. Besides, TLR2 silence reduced C. butyricum-activation NF-κB and JNK signal pathways in ICCs.
CONCLUSIONS: These findings revealed that C. butyricum promoted intestinal motility by regulation of TLR2 in ICCs, which contributed to understand the molecular mechanisms of C. butyricum on UC.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30058712     DOI: 10.26355/eurrev_201807_15533

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  11 in total

1.  Clostridium butyricum Supernatant Regulates the Expression of RORγt in HCT-116 Cells by Inhibiting the TLR2/MyD88/NF-κB Signaling Pathway.

Authors:  Ying Xie; Linyan Zhou; Hui Li; Yan Li
Journal:  Curr Microbiol       Date:  2021-03-06       Impact factor: 2.188

2.  Astragaloside IV alleviates mouse slow transit constipation by modulating gut microbiota profile and promoting butyric acid generation.

Authors:  Qiulan He; Changpeng Han; Liang Huang; Haojie Yang; Jiancong Hu; Huaxian Chen; Ruoxu Dou; Donglin Ren; Hongcheng Lin
Journal:  J Cell Mol Med       Date:  2020-07-06       Impact factor: 5.310

3.  The effect of dietary supplementation with Clostridium butyricum on the growth performance, immunity, intestinal microbiota and disease resistance of tilapia (Oreochromis niloticus).

Authors:  Hongqin Li; Ying Zhou; Huayun Ling; Li Luo; Desheng Qi; Lin Feng
Journal:  PLoS One       Date:  2019-12-09       Impact factor: 3.240

4.  Immunological design of commensal communities to treat intestinal infection and inflammation.

Authors:  Rebecca L Brown; Max L Y Larkinson; Thomas B Clarke
Journal:  PLoS Pathog       Date:  2021-01-19       Impact factor: 6.823

5.  Gut microbiota of patients with different subtypes of gastric cancer and gastrointestinal stromal tumors.

Authors:  Virinder Sarhadi; Binu Mathew; Arto Kokkola; Tiina Karla; Milja Tikkanen; Hilpi Rautelin; Leo Lahti; Pauli Puolakkainen; Sakari Knuutila
Journal:  Gut Pathog       Date:  2021-02-17       Impact factor: 4.181

Review 6.  Gut microbiota-motility interregulation: insights from in vivo, ex vivo and in silico studies.

Authors:  Barbora Waclawiková; Agnese Codutti; Karen Alim; Sahar El Aidy
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 7.  Gut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease.

Authors:  Manasvini Markandey; Aditya Bajaj; Nicholas Edward Ilott; Saurabh Kedia; Simon Travis; Fiona Powrie; Vineet Ahuja
Journal:  Gut Microbes       Date:  2021 Jan-Dec

8.  Intestinal bacteria flora changes in patients with Mycoplasma pneumoniae pneumonia with or without wheezing.

Authors:  Yonghong Jiang; Chunxiu Bao; Xiaoyang Zhao; Yiliu Chen; Yao Song; Zhen Xiao
Journal:  Sci Rep       Date:  2022-04-05       Impact factor: 4.379

9.  CBP22, a Novel Bacteriocin Isolated from Clostridium butyricum ZJU-F1, Protects against LPS-Induced Intestinal Injury through Maintaining the Tight Junction Complex.

Authors:  Tenghao Wang; Jie Fu; Xiao Xiao; Zeqing Lu; Fengqin Wang; Mingliang Jin; Yizhen Wang; Xin Zong
Journal:  Mediators Inflamm       Date:  2021-06-01       Impact factor: 4.711

10.  Clostridium Butyricum ZJU-F1 Benefits the Intestinal Barrier Function and Immune Response Associated with Its Modulation of Gut Microbiota in Weaned Piglets.

Authors:  Jie Fu; Tenghao Wang; Xiao Xiao; Yuanzhi Cheng; Fengqin Wang; Mingliang Jin; Yizhen Wang; Xin Zong
Journal:  Cells       Date:  2021-03-02       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.